Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 161-170 of 406 for multiple

Edit search filters
  1. A Study of Multiple Activity Tracking Devices for Accuracy in Controlled and Free-Walking Conditions

    Rochester, MN

  2. Study Of ACTR087 In Combination With SEA-BCMA In Subjects With Relapsed Or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. A Study To Evaluate MEDI2228 In Subjects With Relapsed/ Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study Of The Effect Of MD1003 In Progressive Multiple Sclerosis (SPI2)

    Scottsdale/Phoenix, AZ

  5. Study To Assess Anti-CD38 Antibody Drug Conjugate In Relapsed Or Refractory Multiple Myeloma

    Jacksonville, FL, Rochester, MN

  6. A Trial To Evaluate Multiple Regimens In Newly Diagnosed And Recurrent Glioblastoma

    Jacksonville, FL, Rochester, MN

  7. Ixazomib Plus Pomalidomide And Dexamethasone In Treating Patients With Relapsed Or Relapsed/Refractory Multiple Myeloma

    Rochester, MN

  8. BT062 In Combination With Lenalidomide Or Pomalidomide And Dexamethasone In Patients With Multiple Myeloma

    Jacksonville, FL

  9. Lenalidomide And Dexamethasone In Treating Patients With Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  10. A Study To Evaluate 3 Dose Schedules Of Daratumumab In Participants With Smoldering Multiple Myeloma

    Jacksonville, FL

.

Mayo Clinic Footer